SlideShare a Scribd company logo
3
Most read
5
Most read
7
Most read
VTAMA
PRESENTED BY-
VARSHA R WADNERE
Vth YEAR PHARM D
DOP- 24-08-2022
TABLE OF CONTENTS
1. Introduction
2. FDA approval
3. Description
4. Chemistry
5. Mechanism of action
6. Dose and administration
7. Dosage and strength
8. Pharmacokinetics
9. Pharmacodynamics
10. Special population
11. Adverse effects
12. Contraindications
13. Storage and handling
14. Cost of the drug
15. References
INTRODUCTION
➢VTAMA cream is a prescription medicine used on the skin (topical) to treat plaque psoriasis in
adults.
➢It is the first unique topical medication to be launched for psoriasis in 25 years, according to a
statement by Dermavant, Vtama's manufacturer.
➢The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that integrates
environmental, dietary, microbial and metabolic cues to control complex transcriptional
programmes in a ligand-specific, cell-type-specific manner.
➢Plays an important tumor-specific role in enhancing or inhibiting carcinogenesis, manages
immune system.
FDAAPPROVAL
➢VTAMA was granted FDA approval on 23-05-2022
DESCRIPTION
➢Generic Name- Tapinarof
➢Pharmacological Class- Aryl hydrocarbon receptor {AhR} agonist.
➢VTAMA cream also contains the following inactive ingredients:
benzoic acid, butylated hydroxytoluene {antioxidant}, citric acid monohydrate, diethylene glycol
monoethyl ether, edetate disodium, emulsifying wax, medium-chain triglycerides, polyoxyl 2 stearyl
ether, polyoxyl 20 stearyl ether, polysorbate 80, propylene glycol, purified water, and sodium citrate
dihydrate.
CHEMISTRY
➢Tapinarof is a white to pale brown powder.
➢Chemically, tapinarof is 3, 5-dihydroxy-4-isopropyl-transstilbene.
➢Also known as (E)-2-isopropyl-5-styrylbenzene-1,3-diol, with the empirical formula C17H18O2,
a molecular weight of 254.32, and the following structural formula.
MECHANISM OF ACTION
➢Tapinarof is an aryl hydrocarbon receptor (AhR) agonist.
➢The specific mechanisms by which VTAMA cream exerts its therapeutic action in psoriasis
patients are unknown.
➢The efficacy of tapinarof in psoriasis is attributed to its specific binding and activation of AhR, a
ligand-dependent transcription factor, leading to the downregulation of proinflammatory
cytokines, including interleukin 17, and regulation of skin barrier protein expression to promote
skin barrier normalization.
DOSE AND ADMINISTRATION
➢Apply a thin layer of VTAMA cream to affected areas once daily.
➢VTAMA cream is not for oral, ophthalmic, or intravaginal use.
DOSAGE AND STRENGTH
➢Cream, 1%
➢Each gram of VTAMA cream contains 10 mg of tapinarof.
PHARMACOKINETICS
➢Absorption
No accumulation was observed with repeat topical application.
Plasma concentration of tapinarof was below the quantifiable limits (BQL) of the assay (lower limit
of quantification was 50 pg/mL) in 68% of the pharmacokinetic samples.
➢Distribution
Human plasma protein binding of tapinarof is approximately 99% in vitro.
➢Elimination
Metabolism
Tapinarof is metabolized in the liver by multiple pathways including oxidation, glucuronidation,
and sulfation in vitro.
PHARMACODYNAMICS
➢Pharmacodynamics of VTAMA cream are unknown.
SPECIAL POPULATION
➢Pediatric Use
The safety and effectiveness of VTAMA have not been established in pediatric patients.
➢Geriatric Use
No overall differences in efficacy, safety, or tolerability were observed between elderly subjects and
younger adult subjects in clinical trials.
ADVERSE EFFECTS
➢Folliculitis
➢Nasopharyngitis
➢Contact dermatitis
➢Headache
➢Pruritus
➢Influenza
➢Two (0.3%) subjects using VTAMA cream developed urticaria.
CONTRAINDICATIONS
➢ NONE.
STORAGE AND HANDLING
How supplied-
VTAMA (tapinarof) cream, 1% is a white to off-white cream. Each gram of VTAMA cream
contains 10 mg of tapinarof.
It is supplied in the following size: 60 g laminated tubes
➢Store at 20°C to 25°C (68°F to 77°F).
➢Do not freeze.
➢Protect from exposure to excessive heat.
➢Keep out of reach of children.
COST OF THE DRUG
➢ The cost for Vtama topical cream 1% is around $1,405 for a supply of 60 grams (1,12,219 INR).
REFERENCES
➢https://www.fda.gov/
➢https://www.pubmed.com/
VTAMA DRUG

More Related Content

PDF
Patient Counselling in Various Common Diseases
PDF
TDM of Lithium.pdf
PDF
SOFTWARE USED IN P'epidemiology.pdf
PDF
DIABETIC FOOT CASE PRESENTATION.pdf
PDF
CASE PRESENTATION ON DIABETES MELLITUS
PDF
SOAP CASE PRESENTATION ON ACUTE GASTRO ENTRITITIS WITH DIABETES MELLITUS AND ...
PDF
CDSCO.pdf
PDF
QUVIVIQ-.pdf
Patient Counselling in Various Common Diseases
TDM of Lithium.pdf
SOFTWARE USED IN P'epidemiology.pdf
DIABETIC FOOT CASE PRESENTATION.pdf
CASE PRESENTATION ON DIABETES MELLITUS
SOAP CASE PRESENTATION ON ACUTE GASTRO ENTRITITIS WITH DIABETES MELLITUS AND ...
CDSCO.pdf
QUVIVIQ-.pdf

More from varshawadnere (20)

PDF
OBSESSIVE COMPULSIVE DISORDER.
PDF
Patient medication counselling.
PDF
Urinary tract infection
PDF
Patient Medication History Interview.
PDF
Migraine.
PDF
Drug Information.
PDF
Chronic Kidney Disease with Hypertension.
PDF
ACUTE RENAL FAILURE
PPTX
ZOLLINGER ELLISON SYNDROME.
PPTX
Patient Counselling for Obese and Hypertensive Patient
PPTX
Radiation poisoning
PPTX
Quality assurance of clinical pharmacy services
PPTX
Drug Information Centre
PPTX
SOCIAL MEDIA- A TOOL FOR SPREADING AWARNESS ON PHARMACOVIGELENCE.
PPTX
URINARY TRACT INFECTION.
PPT
ACUTE RENAL FAILURE-ARF.
PPTX
RHEUMATOID ARTHRITIS.
PPTX
Osteoarthritis case- SOAP FORMAT
PPTX
FLAME PHOTOMETRY
PPTX
HIV- HUMAN IMMUNODEFICIENCY VIRUS
OBSESSIVE COMPULSIVE DISORDER.
Patient medication counselling.
Urinary tract infection
Patient Medication History Interview.
Migraine.
Drug Information.
Chronic Kidney Disease with Hypertension.
ACUTE RENAL FAILURE
ZOLLINGER ELLISON SYNDROME.
Patient Counselling for Obese and Hypertensive Patient
Radiation poisoning
Quality assurance of clinical pharmacy services
Drug Information Centre
SOCIAL MEDIA- A TOOL FOR SPREADING AWARNESS ON PHARMACOVIGELENCE.
URINARY TRACT INFECTION.
ACUTE RENAL FAILURE-ARF.
RHEUMATOID ARTHRITIS.
Osteoarthritis case- SOAP FORMAT
FLAME PHOTOMETRY
HIV- HUMAN IMMUNODEFICIENCY VIRUS
Ad

Recently uploaded (20)

PPTX
Open Quiz Monsoon Mind Game Final Set.pptx
PDF
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
PDF
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
PPTX
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PPTX
Week 4 Term 3 Study Techniques revisited.pptx
PDF
Open folder Downloads.pdf yes yes ges yes
PDF
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
PDF
FourierSeries-QuestionsWithAnswers(Part-A).pdf
PPTX
PPH.pptx obstetrics and gynecology in nursing
PDF
O7-L3 Supply Chain Operations - ICLT Program
PPTX
COMPUTERS AS DATA ANALYSIS IN PRECLINICAL DEVELOPMENT.pptx
PDF
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
PDF
BÀI TẬP TEST BỔ TRỢ THEO TỪNG CHỦ ĐỀ CỦA TỪNG UNIT KÈM BÀI TẬP NGHE - TIẾNG A...
PDF
Introduction-to-Social-Work-by-Leonora-Serafeca-De-Guzman-Group-2.pdf
PDF
Abdominal Access Techniques with Prof. Dr. R K Mishra
PDF
Microbial disease of the cardiovascular and lymphatic systems
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
Open Quiz Monsoon Mind Game Final Set.pptx
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
Week 4 Term 3 Study Techniques revisited.pptx
Open folder Downloads.pdf yes yes ges yes
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
FourierSeries-QuestionsWithAnswers(Part-A).pdf
PPH.pptx obstetrics and gynecology in nursing
O7-L3 Supply Chain Operations - ICLT Program
COMPUTERS AS DATA ANALYSIS IN PRECLINICAL DEVELOPMENT.pptx
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
BÀI TẬP TEST BỔ TRỢ THEO TỪNG CHỦ ĐỀ CỦA TỪNG UNIT KÈM BÀI TẬP NGHE - TIẾNG A...
Introduction-to-Social-Work-by-Leonora-Serafeca-De-Guzman-Group-2.pdf
Abdominal Access Techniques with Prof. Dr. R K Mishra
Microbial disease of the cardiovascular and lymphatic systems
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
Ad

VTAMA DRUG

  • 1. VTAMA PRESENTED BY- VARSHA R WADNERE Vth YEAR PHARM D DOP- 24-08-2022
  • 2. TABLE OF CONTENTS 1. Introduction 2. FDA approval 3. Description 4. Chemistry 5. Mechanism of action 6. Dose and administration 7. Dosage and strength 8. Pharmacokinetics 9. Pharmacodynamics 10. Special population 11. Adverse effects 12. Contraindications 13. Storage and handling 14. Cost of the drug 15. References
  • 3. INTRODUCTION ➢VTAMA cream is a prescription medicine used on the skin (topical) to treat plaque psoriasis in adults. ➢It is the first unique topical medication to be launched for psoriasis in 25 years, according to a statement by Dermavant, Vtama's manufacturer. ➢The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that integrates environmental, dietary, microbial and metabolic cues to control complex transcriptional programmes in a ligand-specific, cell-type-specific manner. ➢Plays an important tumor-specific role in enhancing or inhibiting carcinogenesis, manages immune system.
  • 4. FDAAPPROVAL ➢VTAMA was granted FDA approval on 23-05-2022
  • 5. DESCRIPTION ➢Generic Name- Tapinarof ➢Pharmacological Class- Aryl hydrocarbon receptor {AhR} agonist. ➢VTAMA cream also contains the following inactive ingredients: benzoic acid, butylated hydroxytoluene {antioxidant}, citric acid monohydrate, diethylene glycol monoethyl ether, edetate disodium, emulsifying wax, medium-chain triglycerides, polyoxyl 2 stearyl ether, polyoxyl 20 stearyl ether, polysorbate 80, propylene glycol, purified water, and sodium citrate dihydrate.
  • 6. CHEMISTRY ➢Tapinarof is a white to pale brown powder. ➢Chemically, tapinarof is 3, 5-dihydroxy-4-isopropyl-transstilbene. ➢Also known as (E)-2-isopropyl-5-styrylbenzene-1,3-diol, with the empirical formula C17H18O2, a molecular weight of 254.32, and the following structural formula.
  • 7. MECHANISM OF ACTION ➢Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. ➢The specific mechanisms by which VTAMA cream exerts its therapeutic action in psoriasis patients are unknown. ➢The efficacy of tapinarof in psoriasis is attributed to its specific binding and activation of AhR, a ligand-dependent transcription factor, leading to the downregulation of proinflammatory cytokines, including interleukin 17, and regulation of skin barrier protein expression to promote skin barrier normalization.
  • 8. DOSE AND ADMINISTRATION ➢Apply a thin layer of VTAMA cream to affected areas once daily. ➢VTAMA cream is not for oral, ophthalmic, or intravaginal use.
  • 9. DOSAGE AND STRENGTH ➢Cream, 1% ➢Each gram of VTAMA cream contains 10 mg of tapinarof.
  • 10. PHARMACOKINETICS ➢Absorption No accumulation was observed with repeat topical application. Plasma concentration of tapinarof was below the quantifiable limits (BQL) of the assay (lower limit of quantification was 50 pg/mL) in 68% of the pharmacokinetic samples.
  • 11. ➢Distribution Human plasma protein binding of tapinarof is approximately 99% in vitro. ➢Elimination Metabolism Tapinarof is metabolized in the liver by multiple pathways including oxidation, glucuronidation, and sulfation in vitro.
  • 13. SPECIAL POPULATION ➢Pediatric Use The safety and effectiveness of VTAMA have not been established in pediatric patients. ➢Geriatric Use No overall differences in efficacy, safety, or tolerability were observed between elderly subjects and younger adult subjects in clinical trials.
  • 16. STORAGE AND HANDLING How supplied- VTAMA (tapinarof) cream, 1% is a white to off-white cream. Each gram of VTAMA cream contains 10 mg of tapinarof. It is supplied in the following size: 60 g laminated tubes ➢Store at 20°C to 25°C (68°F to 77°F). ➢Do not freeze. ➢Protect from exposure to excessive heat. ➢Keep out of reach of children.
  • 17. COST OF THE DRUG ➢ The cost for Vtama topical cream 1% is around $1,405 for a supply of 60 grams (1,12,219 INR).